About Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy is a Healthcare company based in San Francisco (United States). Research on cancer immunotherapy is conducted to develop treatments. It operates on a Donation / Grant-Based and HealthTech model. Parker Institute for Cancer Immunotherapy offers products and services including Cancer Immunotherapy Research and Early Career Researcher Awards. Its focus areas include Biotechnology and Cancer Immunotherapy.
Company details
Breakthrough immune therapies are developed by the Parker Institute for Cancer Immunotherapy to turn all cancers into curable diseases. Collaboration with top research institutions, biotech, and pharmaceutical partners is facilitated to accelerate innovation. Focus is placed on removing barriers in cancer research, supporting early career investigators, and translating ideas into real-world treatments. The healthcare sector, specifically cancer immunotherapy, is targeted through a non-profit model.
Products & Services of Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy offers a comprehensive portfolio of products and services, including Cancer Immunotherapy Research and Early Career Researcher Awards.
Research on immunotherapy is conducted to treat cancer.
Grants are provided to early career cancer researchers.
Apps and channels of Parker Institute for Cancer Immunotherapy
its YouTube channel Parker Institute for Cancer Immunotherapy has 279 subscribers and 30 videos.
Videos from Parker Institute for Cancer Immunotherapy
The most watched videos on Parker Institute for Cancer Immunotherapy's YouTube channel, Parker Institute for Cancer Immunotherapy (279 subscribers). Click a video to play it here.
People of Parker Institute for Cancer Immunotherapy
17 people are tracked at Parker Institute for Cancer Immunotherapy (8 in leadership, 2 in board & advisors, 7 in team).
| Name | Role | Group |
|---|---|---|
Sean Parker | Founder, Chairman | Leadership |
Coltin Krauss | Senior Director, Financial Planning & Analysis | Leadership |
Shane Corcoran | Senior Vice President, Strategy, Operations & Communications | Leadership |
Ute Dugan | Chief Medical Officer | Leadership |
Marko Spasic | Head Of Medical And Scientific Partnerships | Leadership |
Christopher Cabanski | Senior Director, Network Clinical Research | Leadership |
Samantha Liang | Alliance And Collaboration Director | Leadership |
Janine Pixley | Senior Director, Business Operations & Network Administration | Leadership |
Michael Polansky | Co-founder; Board Member | Board & advisors |
Tom van Loben Sels | Board Member | Board & advisors |
Sara Coblin | SVP, Finance & Administration | Team |
W. Dale Harding | Controller | Team |
Jennifer Clark | Office Manager And Executive Assistant | Team |
Mini Sanyal | Senior Grants Manager | Team |
Amanda Walther | Executive Assistant | Team |
Monika Lukic | Executive Assistant | Team |
Wendy Du | Human Resources Generalist | Team |
Complete people profiles for Parker Institute for Cancer Immunotherapy
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Parker Institute for Cancer Immunotherapy (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Breakthrough immune therapies are developed by the Parker Institute for Cancer Immunotherapy to turn all cancers into curable diseases. Collaboration with top research institutions, biotech, and pharmaceutical partners is facilitated to accelerate innovation. Focus is placed on removing barriers in cancer research, supporting early career investigators, and translating ideas into real-world treatments. The healthcare sector, specifically cancer immunotherapy, is targeted through a non-profit model.
Parker Institute for Cancer Immunotherapy offers Cancer Immunotherapy Research and Early Career Researcher Awards.